Clorox Co (NYSE: CLX)’s stock price has gone decline by -1.58 in comparison to its previous close of 129.65, however, the company has experienced a -2.59% decrease in its stock price over the last five trading days. fool.com reported 2025-06-05 that It’s been a good year for the consumer staples sector, which is outperforming the S&P 500 (^GSPC 0.01%) year to date with a near 5% gain at the time of this writing. But Clorox has been noticeably left out of the broader sector rally, with the stock down 19% year to date and hovering around a 52-week low.
Is It Worth Investing in Clorox Co (NYSE: CLX) Right Now?
Clorox Co (NYSE: CLX) has a higher price-to-earnings ratio of 22.91x compared to its average ratio. CLX has 36-month beta value of 0.53. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 13 as “hold,” and 1 as “sell.”
The public float for CLX is 122.85M, and currently, short sellers hold a 4.10% ratio of that float. The average trading volume of CLX on June 05, 2025 was 1.61M shares.
CLX’s Market Performance
The stock of Clorox Co (CLX) has seen a -2.59% decrease in the past week, with a -5.52% drop in the past month, and a -14.00% fall in the past quarter. The volatility ratio for the week is 0.78%, and the volatility levels for the past 30 days are at 1.31% for CLX. The simple moving average for the past 20 days is -3.94% for CLX’s stock, with a -17.03% simple moving average for the past 200 days.
Analysts’ Opinion of CLX
Many brokerage firms have already submitted their reports for CLX stocks, with Wells Fargo repeating the rating for CLX by listing it as a “Equal Weight.” The predicted price for CLX in the upcoming period, according to Wells Fargo is $157 based on the research report published on January 07, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see CLX reach a price target of $170, previously predicting the price at $155. The rating they have provided for CLX stocks is “Hold” according to the report published on November 06th, 2024.
Jefferies gave a rating of “Buy” to CLX, setting the target price at $187 in the report published on October 01st of the previous year.
CLX Trading at -7.36% from the 50-Day Moving Average
After a stumble in the market that brought CLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.54% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLX starting from Breber Pierre R, who purchase 4,000 shares at the price of $136.57 back on May 07 ’25. After this action, Breber Pierre R now owns 4,000 shares of Clorox Co, valued at $546,285 using the latest closing price.
Marriner Kirsten, the EVP – Chief People Officer of Clorox Co, sale 7,494 shares at $151.62 during a trade that took place back on Mar 10 ’25, which means that Marriner Kirsten is holding 27,038 shares at $1,136,251 based on the most recent closing price.
Stock Fundamentals for CLX
Current profitability levels for the company are sitting at:
- 0.18 for the present operating margin
- 0.45 for the gross margin
The net margin for Clorox Co stands at 0.1. The total capital return value is set at 0.39. Equity return is now at value 1176.27, with 12.26 for asset returns.
Based on Clorox Co (CLX), the company’s capital structure generated 0.99 points at debt to capital in total, while cash flow to debt ratio is standing at 0.35. The debt to equity ratio resting at 109.04. The interest coverage ratio of the stock is 14.89.
Currently, EBITDA for the company is 736.0 million with net debt to EBITDA at 1.97. When we switch over and look at the enterprise to sales, we see a ratio of 2.62. The receivables turnover for the company is 11.76for trailing twelve months and the total asset turnover is 1.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.74.
Conclusion
To put it simply, Clorox Co (CLX) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
